REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 86 filers reported holding REVANCE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,624,000 | +10.8% | 65,366 | +22.4% | 0.01% | +10.0% |
Q2 2018 | $1,466,000 | -0.8% | 53,414 | +11.3% | 0.01% | -16.7% |
Q1 2018 | $1,478,000 | +20.7% | 47,981 | +40.0% | 0.01% | +50.0% |
Q4 2017 | $1,225,000 | +46.5% | 34,279 | +12.9% | 0.01% | +33.3% |
Q3 2017 | $836,000 | +16.0% | 30,351 | +11.1% | 0.01% | +20.0% |
Q2 2017 | $721,000 | +41.4% | 27,324 | +11.4% | 0.01% | +25.0% |
Q1 2017 | $510,000 | -10.1% | 24,531 | -10.5% | 0.00% | 0.0% |
Q4 2016 | $567,000 | -3.7% | 27,404 | -24.5% | 0.00% | -20.0% |
Q3 2016 | $589,000 | +8.3% | 36,313 | -9.2% | 0.01% | 0.0% |
Q2 2016 | $544,000 | -1.3% | 39,990 | +26.7% | 0.01% | -16.7% |
Q1 2016 | $551,000 | -56.4% | 31,559 | -14.6% | 0.01% | -50.0% |
Q4 2015 | $1,263,000 | -88.7% | 36,968 | -1.4% | 0.01% | 0.0% |
Q3 2015 | $11,154,000 | +1369.6% | 37,481 | +57.9% | 0.01% | +100.0% |
Q2 2015 | $759,000 | +211.1% | 23,738 | +101.4% | 0.01% | +200.0% |
Q1 2015 | $244,000 | – | 11,784 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |